Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 600-896-9 | CAS number: 109089-77-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in chemico
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- From July 9th, 2018 to July 12th, 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442C (In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA))
- Version / remarks:
- EURL ECVAM DB-ALM Protocol n.º 154
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- direct peptide reactivity assay (DPRA)
Test material
- Reference substance name:
- 3-(2-methoxy-5-methylphenyl)-3-phenylpropanoic acid
- EC Number:
- 600-896-9
- Cas Number:
- 109089-77-2
- Molecular formula:
- C17H18O3
- IUPAC Name:
- 3-(2-methoxy-5-methylphenyl)-3-phenylpropanoic acid
- Test material form:
- solid: particulate/powder
Constituent 1
In chemico test system
- Details on the study design:
- Skin sensitisation (In chemico test system) - Details on study design:
TEST SYSTEM
- Cysteine peptide (Ac-RFAACAA-COOH): source RS Synthesis, LLC, lot no. 170622
- Lysine peptide (Ac-RFAAKAA-COOH): source RS Synthesis, LLC, lot no. 170705
- Solvent/vehicle: acetonitrile, based on the results of the preliminary solubility test.
- Preparation of test item stock solution: the test item was dissolved at 100 mM in acetonitrile without sonication.
- Preparation of test item samples for the reactivity with cysteine peptide: 50 µL of test item formulation was incubated with 750 µL of cysteine peptide solution (at 0.667 mM in phosphate buffer at pH 7.5 ± 0.05) and 200 µL of acetonitrile.
- Preparation of test item samples for the reactivity with lysine peptide: 250 µL of test item formulation was incubated with 750 µL of lysine peptide solution (at 0.667 mM in ammonium acetate at pH 10.2 ± 0.05).
CONTROLS (preparation)
- Positive control: 100 mM cinnamaldehyde (purity ≥ 95%, Sigma-Aldrich, lot no. MKBT8955V).
- Positive control for cysteine peptide: 50 µL of cinnamaldehyde at 100 mM in acetonitrile was incubated with 750 µL of cysteine peptide solution (at 0.667 mM in phosphate buffer at pH 7.5) and 200 µL of acetonitrile.
- Positive control for lysine peptide: 250 µL of cinnamaldehyde at 100 mM in acetonitrile was incubated with 750 µL of lysine peptide solution (at 0.667 mM in ammonium acetate at pH 10.2).
- Reference controls: All the reference control samples were prepared in triplicate at the nominal concentration of 0.500 mM of peptide in the solvent specified below.
- Reference control A: acetonitrile (to check calibration curve accuracy)
- Reference Control B: acetonitrile (included at the beginning and at the end of the sequence, to check the stability of the peptide over time)
- Reference Control C: acetonitrile (solvent used both for the test item and the positive control, to check the influence of the test item solvent on the peptide stability)
- Co-elution controls: 100 mM test item in the appropriate buffer.
- Co-elution control (cys p.): 50 µL test item formulation was incubated with 750 µL of cysteine peptide dilution buffer (without cysteine peptide) and 200 µL acetonitrile.
- Co-elution control (lys p.): 250 µL of test item formulation was incubated with 750 µL of lysine peptide dilution buffer (without lysine peptide).
HPLC ANALYSIS
- Equipment: HPLC system (Waters e2695) with autosampler, UV detector (200 nm; Waters 2489), Xbridge Peptide BEH C18 (100 x 2.1 mm; 3.5 µm) HPLC analytical column.
- Conditions: sample temperature 25ºC, column temperature 30ºC, injection volume: 7 µL(cys) or 3 µL(lys), flow rate 0.35 mL/min, total analysis time 20 min.
- mobile phase A: trifluoroacetic acid at 0.1% (v/v) in water
- mobile phase B: trifluoroacetic acid at 0.085% (v/v) in acetonitrile
- System suitability: calibration linearity: r2 > 0.9995 for both peptides; mean peptide concentration of Reference control A = 0.503 (cys) and 0.491 (lys) = 0.5 ± 0.005 mM.
- Analysis sequence: The reference controls B were placed at the beginning and at the end of the analysis (3 repetitions). The reference controls C were placed at the beginning of each repetition. The standards of the calibration curve and the reference controls A were placed in order to be analyzed progressively throughout the sequence. Lysine and cysteine analysis were conducted on separate day and test item was freshly prepared for both assays on each day. The analysis was timed to assure that the injection of the first sample starts 22 to 26 hours after the test item was mixed with the peptide solution. The HPLC analysis time was less than 30 hours.
ACCEPTANCE CRITERIA
- For the positive control, the mean % peptide depletion value must fall within 60.8 - 100.0% (cys) and 40.2 - 69.4 (lys);
- For the positive control, SD (cys) < 14.9% and SD (lys) < 11.6%;
- For the reference controls, CV% of the peak areas for reference controls B, C must be < 15.0%;
- For the reference controls in the analysis sequence, the mean peptide concentration of Reference control C must be 0.5 ± 0.005 mM;
- For the test item replicates, SD (cys) < 14.9% and SD (lys) < 11.6%;
INTERPRETATION OF RESULTS: Cysteine 1:10-only prediction model.
- 0.00 % ≤ mean % depletion ≤ 6.38 % = No or minimal reactivity = Negative DPRA Prediction
- 6.38 % ≤ mean of cysteine and lysine % depletion ≤ 22.62 % = Low reactivity = Positive DPRA Prediction
- 22.62 % ≤ mean of cysteine and lysine % depletion ≤ 42.47 % = Moderate reactivity = Positive DPRA Prediction
- 42.47 % ≤ mean of cysteine and lysine % depletion ≤ 100 % = High reactivity = Positive DPRA Prediction
Results and discussion
- Positive control results:
- The depletion mean of cinnamaldehyde was 49.78 for lysine peptide and 78.17 for cysteine.
In vitro / in chemico
Resultsopen allclose all
- Key result
- Run / experiment:
- mean
- Parameter:
- other: cysteine peptide depletion (%)
- Value:
- 1.14
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: no or minimal peptide reactivity
- Key result
- Run / experiment:
- mean
- Parameter:
- other: lysine peptide depletion (%)
- Value:
- 0.2
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: no or minimal reactivity
- Key result
- Run / experiment:
- mean
- Parameter:
- other: overall average
- Value:
- 0.67
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Appearance of precipitate (if yes, if precipitate was re-solubilised or centrifuged): no precipitate was observed.
- Co-elution: analysis of the chromatograms of the co-elution samples indicated that the test item did not co-elute with the cysteine or lysine peptides.
DEMONSTRATION OF TECHNICAL PROFICIENCY: yes, the expected DPRA prediction for the 10 proficiency substances was obtained. The resulted cysteine and lysine depletion values fall within the respective reference range for 8 out of the 10 proficiency substances for each peptide (8 out of 10 expected in OECD guideline).
ACCEPTANCE OF RESULTS:
The acceptance criteria for the calibration curve samples, the reference and positive controls as well as for the study samples were satisfied.
- Acceptance criteria met for reference controls: yes, the mean peptide concentrations of the reference control C samples was 0.506 mM (cys) and 0.482 mM (lys), within ± 10% of the nominal concentration; and the CV of the mean peptide peak area of the nine reference control B and C samples in acetonitrile was 0.64% (cys) and 1.02% (lys).
- Acceptance criteria met for positive control: yes , for cysteine peptide, the mean percent depletion value was 78.17%, within the acceptance range (60.8 - 100%, SD < 14.9%); and for lysine peptide, the mean percent depletion value was 49.78%, within the acceptance range (40.2 - 69.4, SD < 11.6%).
- Acceptance criteria met for variability between replicate measurements: yes, the maximum SD for the test item replicates was 1.14 < 11.6% for the percent cysteine depletion value, and 0.20 < 14.9%.
Any other information on results incl. tables
Table 1. Test item results: Percent peptide depletion.
|
Depletion in Lysine Peptide % |
Depletion in Cysteine Peptide % |
|
|
Repetition 1 |
0 |
1.54 |
|
|
Repetition 2 |
0.45 |
0.36 |
|
Mean Depletion % |
Repetition 3 |
0.14 |
1.53 |
|
|
Mean |
0.20 |
1.14 |
|
0.67 |
SD (Standard Deviation) |
0.23 |
0.68 |
|
SD Validity criteria |
< 11.6% |
< 14.9% |
|
Table 2. Positive control results: percent peptide depletion.
Cinnamaldehyde |
Depletion in Lysine Peptide % |
Depletion in Cysteine Peptide % |
Repetition 1 |
46.11 |
77.34 |
Repetition 2 |
51.03 |
78.17 |
Repetition 3 |
52.20 |
79.00 |
Mean |
49.78 |
78.17 |
|
|
|
Depletion Validity criteria |
40.2 < Depletion < 69.4 |
60.8 < Depletion < 100 |
Table 3. Reference controls.
|
Lysine Peptide |
Cysteine Peptide |
|
|
Concentration (mM) |
Concentration (mM) |
|
Concentration validity criteria (mM) |
|
Reference A |
0.491 |
0.503 |
|
0.500 ± 0.050 |
Reference C |
0.482 |
0.506 |
|
|
CV % |
CV % |
|
CV validity criteria |
Reference B/C |
1.02 |
0.64 |
|
< 15 % |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test item presents a Cysteine peptide depletion percentage of 1.14% and Lysine peptide depletion percentage of 0.20% i.e. an overall average of 0.67% reflecting no or a minimal reactivity and thus a negative prediction for the DPRA.
- Executive summary:
A Direct Peptide Reactivity Assay has been performed as part of an integrated approach to support the identification of the sensitization potential of the test item. The method was performed according to OECD OECD 442C, under GLP. The aim of the study is to evaluate the reactivity of the test item in chemico by quantifying the depletion of synthetic heptapeptides containing either lysine or cysteine.
A preliminary solubility study was conducted for the test item, and based on the results, the test item was prepared in acetonitrile. Peptide solutions were incubated with 100 mM test item solution or 100 mM cinnamic aldehyde solution (positive control), at ratios of 1:10 for cysteine and 1:50 for lysine. Reference controls and co-elution controls were run in parallel. After 24h incubation at 25ºC, the residual peptide concentrations were evaluated by HPLC-UV (220 nm). The test item presents a Cysteine peptide depletion percentage of 1.14% and Lysine peptide depletion percentage of 0.20% i.e. an overall average of 0.67% reflecting no or a minimal reactivity and thus a negative prediction for the DPRA. The acceptance criteria for the calibration curve samples, the reference and positive controls as well as for the study samples were satisfied. Based on the test results, the test item shows no sensitisation potential.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.